| Protocol Number |
Title |
1996CG033
|
CALGB 8461 Cytogenetic studies in acute leukemia |
1996LS132
|
Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase MT1982-12 |
1996LS275
|
MT1992-20: Aplastic anemia or osteopetrosis: Preparation for marrow transplantation. Standard of Care |
1999CG016
|
D9902 A group wide protocol for collecting and banking pediatric cancer research specimens: An IRSG protocol CCG D9902 |
1999LS032
|
MT1999-08 Cytosine arabinoside and mitoxantrone for patients with juvenile myelomonocytic leukemia receiving repeat stem cell transplantation |
1999LS060
|
MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia |
1999LS073
|
MT1999-20 Hematopoietic cell transplantation in children with juvenile myelomonocytic leukemia |
2000LS040
|
MT2000-12 Busulfan, Cyclophosphamide, and Melphalan Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Hematological Malignancies |
2001CG051
|
ANBL0032 Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High-Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue |
2001LS049
|
MT2001-02: Allogeneic Transplant for Hematological Malignancy |
2001LS058
|
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy |
2002LS014
|
Hematopoietic Stem Cell Transplantation in High Risk Patients with Fanconi Anemia MT2002-02 |
2002LS032
|
MT1999-06: Vaccination with Tetanus Toxoid and Keyhold Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses |
2002LS097
|
Twin Cities Brachytherapy Study for Ductal Carcinoma in Situ: A Phase II Trial |
2003CG061
|
AGCT0132 A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Extracranial Germ Cell Tumors |
2003NT024
|
GOG Protocol 0210: A Molecular Staging Study of Endometrial Carcinoma |
2003NT028
|
COG AALL03B1: Classification of Acute Lymphoblastic Leukemia |
2003NT030
|
Sentinel Lymph Node Biopsy before Preoperative Chemotherapy: Factors Associated with Non-Sentinel Lymph Node Metastases |
2003NT036
|
ALTE03N1 Key Adverse Events After Childhood Cancer (COG study) |
2003NT047
|
CALGB 140202: The CALGB Lung Cancer Tissue Bank |
2003NT049
|
ABTR01B1 A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors |
2003NT050
|
ACNS02B3 A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens |
2003NT051
|
COG 9346 Hepatoblastoma Biology Study and Tissue Bank |
2003NT056
|
Methods for Tobacco Exposure Reduction in Human - Study 2: Comparisons of Nicotine-Free Cigarettes, Extra Low Nicotine Cigarette vs. Medicinal Nicotine; Part of Hatsukami's Tobacco Exposure Reduction |
2003NT064
|
Metabolic Syndrome in Childhood Cancer Survivors |
2004CG009
|
COG AALL0232 "HighRisk B-precursor Acute Lymphoblastic Leukemia" |
2004CG029
|
COG ACNS0331: A Study Evaluating Limited Target Volumne Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial |
2004CG064
|
COG ARST0331: Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma |
2004LS001
|
MT2003-13 Autologous Transplantation for Multiple Myeloma |
2004LS006
|
MT2003-15 Use of Cyclophosphamide/Fludarabine to Promote in vivo Expansion of Donor Lymphocyte Infusion s(DLI) to Enhance Efficacy after Allogeneic Transplant |
2004LS034
|
MT2004-03: A Dose Escalation Study of CD4+ CD25+ Cells in Adult Patients Undergoing HLA-Identical Sibling Donor Peripheral Blood Progenitor Cell (PBPC) Transplantation" MT2004-03: A Clinical Trial of Adult CD4+ CD25+ Regulatory T Cells in BMT Recipients |
2004LS042
|
MT2003-23: Reduced Intensity Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Supplemented with Donor Natural Killer (NK) Cell Infusions in Patients with High Risk Myeloid Malignancies who are Unsuitable for Fully Myeloablative Transplantation with a Phase II, Open Label Study of Bortezomib in the Preparative Regimen |
2004LS060
|
A Phase II Pilot Study of Multi-Agent Neo Adjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Adenocarcinoma |
2004UC035
|
MT2004-04: A Multicenter, Prospective Trial to Evaluate the Role of NK Cell Kir Epitope Mismatch on Mortality and Disease Relapse in T-Cell Depleted Hematopoietic Stem Cell Transplantation for HLA-C Mismatch, Unrelated Donors for Myeloid Malignancies |
2005CG018
|
COG ADVL04P2: A Feasibility Pilot and Phase II Study of Chemoimmunotherapy with Epratuzumab (IND#12034) for Children with Relapsed CD22-positive Acute Lymphoblastic Leukemia (ALL) |
2005CG028
|
COG AALL0331: Standard Risk B-Precursor Acute Lymphoblastic Leukemia |
2005CG061
|
MT2005-22: Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia (CTN 0301) |
2005LS006
|
Breast MRI Assessment of Tumor Viability After Radiofrequency Ablation (RFA) |
2005LS023
|
MT2004-30: Dose Escalation of Total Marrow Irradiation Added To An Alkylator-Intense Conditioning Regimen For Patients with High Risk or Relapsed Solid Tumors |
2005LS036
|
MT2005-02: Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen |
2005LS043
|
MT2005-10: Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen |
2005LS048
|
MT2004-24: Autologous Peripheral Blood Stem Cell Transplant for Patients with Lymphoma |
2005LS068
|
Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies |
2005LS075
|
MT2005-25: Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia |
2005LS080
|
An Evaluation of PET CT Imaging as a Predictor of Response to Preoperative Chemotherapy for Soft Tissue Sarcoma |
2005LS083
|
Phase II Clinical Study of Weekly Topotecan in Combination with Bevacizumab in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Who Have Failed Prior Systemic Chemotherapy |
2005NT018
|
A Randomized Phase II Study of Zoledronic Acid (Zometa) in the Prevention of Osteoporosis In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Study # CZOL446EUS29, MT2005-06) |
2005NT019
|
A Non-Interventional Prospective Study of the Correlation of the Precision Therapeutics, Inc. Chemoresponse Assay with Progression-free Survival in Patients with Recurrent Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer |
2005NT023
|
Capillary Electrophoresis of HCCC (Hepatocellular Carcinoma) Lesions, Untreated and Treated with Chemoembolization Containing Doxorubicin |
2005NT026
|
AALL03N1 Understanding the Ethnic and Racial Differences in Survival Among Children with Acute Lymphoblastic Leukemia |
2006CG003
|
COG AOST0331: A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy |
2006CG023
|
COG ARET0332: A Study of Unilaterial Retinoblastoma with and without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy |
2006CG033
|
COG ADVL0413: A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772, IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias |
2006CG044
|
MT2006-18 (CTN 0402): A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis after HLA-Matched, Related Peripheral Blood Stem Cell Transplantation |
2006CG045
|
CTSU/ECOG PAACT-1: Program for the assessment of clinical cancer tests (PACCT-1) trial assigning individualized options for treatment: the TAILORx trial |
2006CG059
|
MT2006-26 COG AAML0531: A Phase III Randomized Trial of Gemtuzumab Ozogamicin Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults |
2006CG060
|
ECOG 2805: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma |
2006IS006
|
A prospective, randomized, double-blind, stratified, multi-center, 2-arm trial of the continued efficacy and safety of Zometa (every 4 weeks vs. every 12 weeks) in patients with documented bone metastases from breast cancer (Study No. CZOL446E2352) |
2006IS047
|
A Phase 1 Pharmacodynamic Study of CP-751,871 as Neoadjuvant Treatment for Early Breast Cancer |
2006LS016
|
Phase II Study of Naltrexone for the Treatment of Hormone-Refractory, Metastatic Breast Cancer |
2006LS032
|
MT2005-21: Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
2006LS046
|
A Randomized Phase II Study of IL-2 With or Without an Allogeneic Large Multivalent Immunogen (LMI) Vaccine for the Treatment of Stage IV Melanoma |
2006LS057
|
MT2006-09: Phase I Open Label, Single Arm Escalation Trial to Evaluate the Biodistribution and Safety of BU-12 in Patients with Advanced Leukemia |
2006LS058
|
MT2006-20 CTN 0501 - Multi-center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients with Leukemia and Myelodysplasia |
2006NT001
|
Biomarker with Biological Function in Ovarian Carcinoma/Diagnostic Markers for Ovarian Cancer: Detection of Novel Cell Adhesion Proteins in Patients' Specimens |
2006NT007
|
Diagnostic Prostate Magnetic Resonance Imaging at 3 Tesla with an Endorectal Coil |
2006NT012
|
MT2006-27: Bone Mineral Resorption In Children After Hematopoetic Stem Cell Transplantation |
2006NT014
|
Bupropion + Placebo or Bupropion + Naltrexone for Smoking Cessation |
2006NT018
|
Menstrual Phase and Depression Symptoms in Acute Smoking Abstinence |
2006NT021
|
Secreted Biomarkers in Prostate Cancer Detection and Identification of Cancer Altered Proteins in Human Prostate Secretions |
2006NT036
|
MT2007-16R Pilot Study of Vascular Function During Hematopoietic Cell Transplantation |
2006UC008
|
MT2006-04: Head Start III: Dose Intensive Chemotherapy for Children Less than Ten Years of Age Newly Diagnosed with Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation with Myeloablative Chemotherapy (Thiotepa and Carboplatin, with or without Etoposide) and Autologous Stem Cell Rescue |
2006UC048
|
Phase I and II Study of Stereotactic Body Radiation Therapy (SBRT) for Low and Intermediate Risk Prostate Cancer |
2007CG010
|
COG ADVL0612: A Phase I Study of Sunitinib, an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors |
2007CG012
|
GOG Protocol 0212: A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 (IND#70177) Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy |
2007CG023
|
MT2006-25: CTN 0403 - A Randomized Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Cell Transplantation |
2007CG034
|
COG AALL0434: Intensified Methotrexate, Nelarabine and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) |
2007CG038
|
COG ARST0531: Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC), versus VAC Alternating with Vincristine and Irinotecan for Patients with Intermediate Risk Rhabdoymyosarcoma |
2007CG045
|
Erwinase Master Treatment Protocol (erwinia asparaginase) |
2007CG049
|
COG AHOD03P1: Treatment of Children with Newly Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease (LPHD) |
2007CG050
|
CALGB 50401: A randomized phase II trial of rituximab vs. lenalidomide (Revlimid, CC-5013) vs. rituximab + lenalidomide in recurrent follicular non-Hodgkin lymphoma (NHL) that is not rituximab-refractory |
2007CG051
|
CALGB 10602: A randomized phase II trial of azacytidine with or without the histone deacetylase inhibitor entinostat for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukemia (dysplastic type), and acute myeloid leukemia with multilineage dysplasia. |
2007CG058
|
COG AALL0433: Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies |
2007CG068
|
COG AAML0431: The Treatment of Down Syndrome Children with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Under the Age of 4 Years |
2007CG075
|
COG AREN0532: Treatment for Very Low, Low, and Secondary Risk Favorable Histology Wilms Tumor. |
2007CG076
|
ASCT0521: Phase II Open Label Study Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplant. |
2007CG077
|
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated with High Grade Unresectable Malignant Peripheral Nerve Sheath Tumors |
2007CG081
|
ECOG 1505: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely resected Stage 1B (>/= 4 cm) - Non- Small Cell Lung Cancer. |
2007CG083
|
CALGB 140503: Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (<2 cm) Peripheral Non-Small Cell Lung Cancer |
2007CG096
|
ARST0332 - Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age |
2007CG113
|
COG ACNS0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET patients. |
2007IS025
|
A two-arm randomized open label phase 2 study of CP-751, 871 in combination with exemestane versus exemestane alone as a first line treatment for postmenopausal patients with hormone receptor positive advanced breast cancer (Pfizer A4021004) |
2007IS026
|
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma (AVF4095g) |
2007IS041
|
Phase II Study of the Trifunctional Bispecific Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab in Patients with HER-2/Neu Overexpressing (3+ by Dako Hercep Test? or FISH+) Metastatic Breast Cancer Progressing after Trastuzumab Treatment |
2007IS056
|
A double-blind, randomized, placebo-controlled phase III study to assess the efficacy of recMAGE-A3 + AS15 Antigen Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-positive Non-Small Cell Lung Cancer (GSK 109493) |
2007IS088
|
A Multi-Center, Open-Label, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of Combretastatin A-4 Phosphate in Combination with Paclitaxel and Carboplatin in Comparison with Paclitaxel and Carboplatin Against Anaplastic Thyroid Carcinoma (OXiGENE OXC4T4-302) |
2007IS095
|
Protherics PR001-CLN-pro016: An Open Label Treatment Protocol for the Use of Voraxase as Adjunctive Treatment for Patients Experiencing or Are At Risk of Methotrexate Toxicity. |
2007IS117
|
Amgen 20050252: A Phase I Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors |
2007IS134
|
Registration Phase III Study of Lucanix (Belagenpumatucel-L) in Advanced Non-small Cell Lung Cancer: An International Multicenter, Randomized, Double-blinded, Placebo-controlled Study of Lucanix Maintenance Therapy for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One Regimen of Front-line, Platinum-based Combination Chemotherapy (NovaRx NR001-03) |
2007LS019
|
Phase I Clinical Trial of Trametes Versicolor in Women with Breast Cancer |
2007LS022
|
MT2006-01: Phase I Study of Infusion of Umbilical Cord Blood (UCB) Derived CD25+ CD4+ T-Regulatory (Treg) Cells After Non-Myeloablative Cord Blood Transplantation |
2007LS064
|
MT2007-12: Allogeneic Natural Killer Cells with Rituximab in Patients with CD20 Positive Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia ALSO -- Strategies to Increase Sensitivity of CLL Tumor Cells to Natural Killer Cell-Immune-Mediated Cytolysis |
2007LS065
|
MT2007-11R: Open-Label Single-Arm Pilot Study of Deferasirox (Exjade) in Adult Allogenic Hematopoietic Stem Cell Transplant Recipients with Transfusional Iron Overload |
2007LS072
|
MT2007-07: Conditioning for Graft Failure after Hematopoietic Stem Cell Transplantation |
2007LS094
|
A Phase II Study of an Allogeneic Large Multivalent Immunogen (LMI) Vaccine for the Treatment of Stable, Metastatic Breast Cancer |
2007NT029
|
Genetic Epidemiology of Osteosarcoma |
2007NT032
|
Human Laboratory Study of Varenicline in Smokers |
2007NT042
|
The clearance of tobacco carcinogen biomarkers after smoking cessation |
2007NT053
|
Promoting Home Smoking Restrictions: Biomarker Feedback to Cohabitating Smoking and Non-Smoking Adults. |
2007NT059
|
ABTR06C1: Pharmakokinetics of Daunomycin in Children |
2007NT070
|
The Pharmacokinetics of a 41 Ca Marker for Bone Turnover in Breast Cancer Patients Treated with an Aromatase Inhibitor and Bisphosphonate. |
2007NT078
|
Empowering Cancer Survivors through Information Technology |
2007NT079
|
Neurocognitive and White Matter Changes in Adult Allogeneic Non-myeloblative Hematopoietic Cell Transplant Survivors: A Pilot Study |
2007NT080
|
Magnetic Resonance Imaging of the Prostate at 7 Tesla |
2007NT085
|
COG ACCL05C1: A Group-Wide Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy. |
2007NT091
|
COG AREN03B2: Renal Tumors Classification, Biology and Banking Study. |
2007NT092
|
AHOD04B1 Hodgkin's Disease Banking Study |
2007NT093
|
Determining and comparing the pharmacokinetics of deuterated phenanthrene in smokers after oral dosing and incorporation into cigarettes |
2007NT102
|
COG AALL05B1: A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Samples. |
2007NT121
|
A Phase I Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin (FK463) in Children (2-5yrs and 6-11 yrs) and Adolescents (12-16 yrs.) with Esophageal Candidiasis or other Invasive Candidiasis (Astellas 9463-CL-2101) |
2007NT123
|
2007-18R: Chronic GVHD Cohort Protocol |
2007NT126
|
CALGB 150007: Contrast Enhanced Breast MRI and Correlative Science Studies to Characterize Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer- RUNS IN TANDEM WITH CALGB 150012, PLEASE SEE 2007NT140 FOR COMPLETE INFORMATION FOR BOTH PROTOCOLS. |
2007NT127
|
Randomized Trial of PEITC as a Modifier of NNK Metabolism in Smokers |
2007NT129
|
Oral Tobacco as Harm Reduction Method for Smokers: Study 1: Preference, Health Effects and Efficacy of Four Oral Tobacco Products for Smoking Cessation |
2007NT140
|
CALGB 150012: Contrast-Enhanced Breast MRI and MRS for Evaluation of Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer. (Must be Enrolled in CALGB 150007) |
2007NT148
|
Fetal Cells Present in the Maternal Circulation |
2007NT151
|
Quality of Life in Survivors of Non-Hodgkins Lymphoma |
2007NT158
|
Community Based Dialogue for Action Against Colorectal Cancer in Minnesota American Indians |
2007NT160
|
Tobacco Treatment Among Racial./Ethnic Minority Smokers |
2007NT162
|
Improving The School Food Environment - Part 2 and Part 3 |
2007NT167
|
Development and Validation of Methods to Increase Parent Participation in School Welllness Policy Initiatives in Utah - Part 3 |
2007UC002
|
MT2006-07 Reduced Intensity Hematopoietic Cell Transplantation for Patients with Resistant Langerhans Cell Histiocytosis |
2008CG030
|
ANBL0531 Response-and Biology-based Therapy for Intermediate-risk Neuroblastoma |
2008CG045
|
CALGB 50501: A Phase II Trial of Bortezomib (NSC #681239) + Lenalidomide (RevlimidTM, CC-5013) (NSC #703813) for Relapsed/Refractory Mantle Cell Lymphoma |
2008CG046
|
CALGB 10403 An Intergroup Phase II Clinical Trial for Adolescents and Young Adults with Untreated Acute Lymphoblastic Leukemia |
2008CG048
|
MT2008-07R: 07-REV: Evaluation of Lenalidomide as Maintenance Therapy Post Allogeneic Hematopoietic Cell Transplantation for High Risk Multiple Myeloma |
2008CG050
|
COG AALL07P2 Pharmacology and Toxicity of Erwinia Asparaginase (Erwinase; Cristantaspase; IND 290) Following Allergy to PEG-Asparaginase in Treatment of Children with Acute Lymphoblastic Leukemia (ALL) |
2008CG069
|
COG ADVL0714 "A Phase I Study of VEGF Trap (NSC# 724770, IND #100137) in Children with Refractory Solid Tumors" |
2008CG076
|
CALGB 30504: Combination Chemotherapy With or Without Maintainence Sunitinib Malate (IND 74019; NSC 736511) for Untreated Extensive Stage Small Cell Lung Cancer: A phase IB/Randomized Phase II study |
2008CG099
|
MT2008-30: A Multi-Center, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of Umbilical Cord Blood (UCB) from Unrelated Donors in Patients with Hematologic Malignancies (2008-30) |
2008CG100
|
COG AALL0631: A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND#76431; NSC#617807) |
2008CG102
|
CALGB 30704 A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib (NSC#736511, IND#74019) or Pemetrexed Plus Sunitinib in the Second-line Treatment of Advanced Non-small Cell Lung Cancer |
2008CG125
|
COG AAML07P1 A Phase II Pilot Study of Bortezomib (PS-341, Velcade) Combined with Reinduction Chemotherapy in Children and Young Adults with Recurrent, Refractory or Secondary Acute Myeloid Leukemia |
2008CG146
|
GOG 0251: Phase II Trial of NCI-Supplied Agent: Bevacizumab for Recurrent Sex Cord-Stromal Tumors of the Ovary |
2008CG153
|
MT2008-42: Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response |
2008CG157
|
COG AREN0533 Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors |
2008CG164
|
COG ADVL0812 A Phase I Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children with Relapsed/Refractory Solid Tumors and Leukemia |
2008IS026
|
A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients with Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy (Pharmion: AMR-PH-GL-2007-CL-001) |
2008IS028
|
A Study to Determine the Activity of SCH 717454 in Subjects with Osteosarcoma or Ewing's Sarcoma that has Relapsed After Standard Systemic Therapy |
2008IS034
|
A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used for Primary Therapy of Proven or Probable Invasive Aspergillosis |
2008IS061
|
A Phase III Randomized, Double-Blind, Placebo-Controlled Study of Sorafenib and Adjuvant Treatment for Hepatocellular Carcinoma After Surgical Resection or Local Ablation |
2008IS063
|
A Phase 1b Study of LY573636-Sodium in Combination with Sunitinib Malate in Patients with Metastatic Renal Cancer |
2008IS066
|
Axitinib (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: Axis Trial |
2008IS067
|
A Pivotal Trial to Determine the Efficacy and Safety of AP23573 When Administered as Maintenence Therapy to Patients with Metastatic Soft Tissue or Bone Sarcomas |
2008IS072
|
A Multicenter, Randomized, Double-Blind, Phase 3 Study of Sunitinib Plus Prednisone versus Prednisone in Patients with Progressive Metastatic Hormone Refractory Prostate Cancer After Failure of a Docetaxel-Based Chemotherapy Regimen |
2008IS084
|
A Phase II Study of HyperAcute Pancreatic Cancer Vaccine in Combination with Chemotherapy and Chemoradiotherapy in Subjects with Surgically Resected Pancreatic Cancer |
2008IS086
|
MT2008-26: Defibrotide for Hematopoietic Stem Cell Transplant (SCT) Patient With Severe Hepatic Veno-occlusive Disease (VOD): A Treatment IND Study (Under CFR 312.34) |
2008IS090
|
H3E-MC-JMIG: Phase III Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed versus Etoposide, Cisplatin and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other than Predominantly Squamous Cell Histology |
2008IS091
|
A Randomized, Multicenter, Phase II Study of the Efficacy and Safety of Trastuzumab-MCC-DMI vs Trastuzumab (Herceptin?) and Docetaxel (Taxotere?) in Patients with Metastatic Her2-Positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease (TDM4450g) |
2008IS096
|
VEG108844 A Study of Pazopanib Versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma |
2008IS117
|
A double-blind, randomized, placebo-controlled Phase III study to assess the efficacy of recMAGE-A3 + AS15 ASCI as adjuvant therapy in patients with MAGE-A3 positive resected stage III melanoma (GSK 2132231) |
2008IS118
|
A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
|
2008IS123
|
An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone |
2008IS151
|
A Phase IIIb Open-Label, Multi-Centre Immunization Study to Evaluate the Safety of GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine Administered Intramuscularly According to a 0,1,6-Month Schedule in Female American and Canadian Subjects Who Received the Active Control Hepatitis A Vaccine in the 580299/008 Study |
2008LS035
|
Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life |
2008LS043
|
Phase II Trial of Bortezomib and Rituximab for Patients with Post Transplant Lymphoproliferative Disorders (PTLD) MT2008-05R |
2008LS044
|
MT2008-06R: Phase II Trial of Velcade Plus Vorinostat in the Treatment of High Risk MDS and Relapsed/Refractory AML |
2008LS047
|
WCC #50 - Phase I Trial of Lenalidomide in Combination with Liposomal Doxorubicin for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer |
2008LS110
|
MT2008-36: Haploidentical Donor NK Cell Adoptive Therapy and Double T Cell Depleted Umbilical Cord Blood Transplantation With Post-Transplant IL-2 Immune Therapy For Refractory Acute Myeloid Leukemia
|
2008LS112
|
A Therapeutic Trial of Decitabine (Dacogen) and Vorinostat (SAHA) in Combination with Chemotherapy (Vincristine, Prednisone, Doxorubicin and PEG-Asparaginase) for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) MT2008-29R |
2008LS139
|
MT2008-38: A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies |
2008NT001
|
Biomarker Feedback for Smoking Cessation |
2008NT003
|
Improving NRT Adherence and Outcomes in Homeless Smokers |
2008NTCG058
|
COG AEWS07B1 A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens |
2008NTCG059
|
AALL06N1 A Study of Neurocognitive Function in Children Treated for ALL |
2008NTCG085
|
COG AOST06B1 A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens |
2008NTCG101
|
COG ANBL00B1 "Neuroblastoma Biology Studies" |
2008NTCG128
|
COG ADVL06B1 A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children with Cancer |
2008NTCG149
|
GOG 0215: A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Risk-Reducing Surgery That Results in Removal of Both Ovaries |
2008NTCG161
|
COG ACCL0731 Glutamic Acid to Decrease Vincristine Toxicity in Children with Cancer |
2008NTLS060
|
The Effect of Enalapril on Doxorubicin Exposure in Adjuvant Breast Cancer Treatment |
2008NTLS087
|
2008-13R: In Vivo Measurement of DNA and Protein Adducts in Fanconi Anemia and Non-Fanconi Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation |
2008NTLS093
|
Efficacy of an Energy Conservation Course for Persons with Bone Marrow Transplants |
2008NTLS103
|
Iron Overload in Allgeneic Hematopoietic Cell Transplantation |
2008NTLS104
|
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer |
2008NTLS109
|
Clinical Response to Biomarker Documentation of Child Secondhand Smoke Exposure |
2008UC162
|
MT2008-41 A Pilot Study of Matched Unrelated Donor Hematopoietic Stem Cell Transplant for Patients with High Risk Sickle Cell Disease and Other Non-Malignant Red Cell Disorders Using a Reduced Intensity Preparative Regimen and Haplo-Identical Mesenchymal Stromal Cells to Achieve Stable Mixed Chimerism |
2009CG014
|
COG ADVL0821 A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, IND# 100947, NSC# 742460) in Children With Relapsed/Refractory Solid Tumors |
2009CG019
|
GOG 240: A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #7921)Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix |
2009CG030
|
GOG 249: A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma |
2009CG038
|
COG ADVL0813, A Phase I Study of IMC-A12 (Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody) in Combination with CCI-779 (Temsirolimus) in Pediatric Patients with Recurrent or Refractory Solid Tumors |
2009CG061
|
CALGB 30506 A Randomized Phase III Trial of Adjuvant Therapy in Earlystage Non-Small Cell Lung Cancer Evaluating the Potential Utility of a Genomic Prognostic Model to Identify Patients as Candidates for Adjuvant Chemotherapy |
2009CG113
|
ADVL0912: A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma |
2009IS008
|
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas |
2009IS048
|
An Open-label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma (Abraxis BioScience CA033) |
2009NTCG002
|
Pilot Study of Financial impact of Allogeneic Stem Cell Transplant |
2009NTCG017
|
COG ACCL0431 A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children |
2009NTCG026
|
COG ALTE05N1 Umbrella Long-Term Follow-Up Protocol |
2009NTCG043
|
GOG 214: Phase II Double Blind Randomized Trial Evaluating the Biological Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer |
2009NTLS024
|
Diagnostic Magnetic Resonance Imaging and Spectroscopy of the Ovaries at 3 Tesla (T) |
2009NTLS077
|
Green Tea and Reduction of Breast Cancer Risk |
2009UC052
|
T2005-003: A Study of Bortezomib With Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia |
MT2000-09
|
A Study of Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed by Matched Sibling Donor Hematopoietic Cell Transplantation in Patients with Fanconi Anemia |
MT2002-07
|
Allogeneic Hematopoietic Stem Cell Transplant For Patients with High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen. |
MT2002-12
|
Allogeneic Hematopoietic Stem Cell Transplant for Patients with Immunologic or Histiocytic Disorders Using A Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism |
MT2004-09
|
Phase II Study of Combined Laronidase (Aldurazyme TM) Enzyme Replacement Therapy (ERT) with Hematopoietic Stem Cell Transplantation (HSCT) for Hurler Syndrome (MPS IH) |
MT2006-05
|
Total Body Irradiation Dose De-Escalation Study in Patients with Fanconi Anemia Undergoing Alternate Donor Hematopoietic Cell Transplantation |
MT2006-13
|
Autologous Peripheral Blood Stem Cell Transplant for Acute Non-Lymphocytic Leukemia (ANLL) |
MT2007-05R
|
Late Effects in Survivors of Stem Cell Transplantation, Pediatric Blood Disorders or Cancer |
MT2007-10
|
Intrathecal Enzyme Replacement Therapy for Patients with Mucopolysaccharidosis Type I (Hurler Syndrome) |
MT2008-20
|
Allogeneic Transplantation For Severe Osteopetrosis |
Clinical Trials Help